Evidence map›Paper›PMID 35354456›Full record

Trial reportBMC health services research2022

Implementation strategies for integrating pre-exposure prophylaxis for HIV prevention and family planning services for adolescent girls and young women in Kenya: a qualitative study.

Stephanie D Roche, Gena Barnabee, Victor Omollo, Felix Mogaka, Josephine Odoyo, Elizabeth A Bukusi, Jennifer F Morton, Rachel Johnson, Connie Celum, Jared M Baeten and 1 more

Registry-linked trialOpen access · goldAbstract readClinical Trial
In one paragraph

Trial report in BMC health services research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03490058 (A Cohort for Evaluation of Open-label PrEP Delivery Among Kenyan and South African Women), which is not on this map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.4field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03490058 completednot on this map

A Cohort for Evaluation of Open-label PrEP Delivery Among Kenyan and South African Women: The POWER Cohort

TypeobservationalSponsorUniversity of WashingtonRan2017 to 2021Enrolled2,255ConditionsHIV/AIDSArmsTruvada
3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Stephanie D RocheDepartment of Global Health, University of Washington, 325 Ninth Avenue, Seattle, WA, 98104, USA. sroche@uw.edu.
Gena BarnabeeDepartment of Global Health, University of Washington, 325 Ninth Avenue, Seattle, WA, 98104, USA.
Victor OmolloCentre for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya.
Felix MogakaCentre for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya.
Josephine OdoyoCentre for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya.
Elizabeth A BukusiDepartment of Global Health, University of Washington, 325 Ninth Avenue, Seattle, WA, 98104, USA.
Jennifer F MortonDepartment of Global Health, University of Washington, 325 Ninth Avenue, Seattle, WA, 98104, USA.
Rachel JohnsonDepartment of Global Health, University of Washington, 325 Ninth Avenue, Seattle, WA, 98104, USA.
Connie CelumDepartment of Global Health, University of Washington, 325 Ninth Avenue, Seattle, WA, 98104, USA.
Jared M BaetenDepartment of Global Health, University of Washington, 325 Ninth Avenue, Seattle, WA, 98104, USA.
Gabrielle O'MalleyDepartment of Global Health, University of Washington, 325 Ninth Avenue, Seattle, WA, 98104, USA.
University of Washington · USKenya Medical Research Institute · KESeattle University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAcross sub-Saharan Africa, ministries of health have proposed integrating pre-exposure prophylaxis (PrEP) for HIV prevention into family planning (FP) services to reach adolescent girls and young women (AGYW); however, evidence on effective implementation strategies is still limited. We conducted a qualitative study of integrated PrEP-FP service implementation at two FP clinics in Kisumu, Kenya.

methodsFrom June 2017 to May 2020, the Prevention Options for Women Evaluation Research (POWER) study enrolled 1000 sexually active, HIV-negative AGYW age 16 to 25. Actions taken to implement PrEP were captured prospectively in 214 monitoring and evaluation documents and 15 interviews with PrEP implementers. We analysed data using conventional and directed content analysis, with the latter informed by the Consolidated Framework for Implementation Research (CFIR) and the Expert Recommendations for Implementing Change (ERIC) compilation.

resultsPOWER deployed a variety of implementation strategies to train and educate stakeholders (e.g., having new providers shadow PrEP providers); develop stakeholder interrelationships (e.g., organizing support teams with protected time to reflect on implementation progress and make refinements); provide technical assistance; and change physical infrastructure and workflow. Although these strategies reportedly influenced contextual factors across four of the five CFIR domains, they primarily interacted with contextual factors relevant to inner setting, especially implementation climate and readiness for implementation. Overall, implementing PrEP proved easier and less labor-intensive at a private, youth-friendly clinic than a public FP clinic, largely because the baseline structural characteristics (e.g., space, workflow) and organizational mission of the former were more conducive to offering AGYW-centered care. Nevertheless, adoption of PrEP delivery among non-study staff at both sites was low, likely due to the widespread perception that PrEP was not within their scope of work.

conclusionsSome FP clinics may be "lower-hanging fruit" than others for PrEP implementation. Approaching PrEP implementation as a behavioral intervention for FP providers may help ensure that providers have the requisite capability, opportunity, and motivation to adopt the clinical innovation. In particular, PrEP implementers should assess the need for implementation strategies that support providers' clinical decision-making, establish worker expectations and accountability, and address workload constraints.

trial registrationClinical Trial Number: NCT03490058 .

Indexed as

Anti-HIV AgentsHIV InfectionsPre-Exposure ProphylaxisAdolescentAdultFamily Planning ServicesFemaleHumansKenyaYoung AdultAnti-HIV AgentsDelivery of health care, integratedFamily planning servicesHIV infectionsImplementation scienceKenyaPre-exposure prophylaxis

Identifiers

PMID35354456
PMCPMC8969252
OpenAlexW4220991356

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.